Michael J Walker

Author PubWeight™ 36.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Responsiveness of the Neck Disability Index in patients with mechanical neck disorders. Spine J 2009 1.94
2 A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma. Ann Surg Oncol 2007 1.49
3 Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2005 1.33
4 Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells. Clin Cancer Res 2007 1.16
5 The Functional Movement Screen: a reliability study. J Orthop Sports Phys Ther 2012 1.13
6 Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005 1.09
7 Markers of exacerbation severity in chronic obstructive pulmonary disease. Respir Res 2006 1.04
8 Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers. Clin Cancer Res 2007 1.02
9 Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha. Clin Cancer Res 2008 1.02
10 Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc Natl Acad Sci U S A 2010 0.99
11 Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol 2006 0.99
12 Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma. World J Surg Oncol 2008 0.96
13 Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy. Cancer Immunol Immunother 2005 0.96
14 The immediate effects of thoracic spine and rib manipulation on subjects with primary complaints of shoulder pain. J Man Manip Ther 2009 0.95
15 A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma. J Immunother 2011 0.93
16 Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery. World J Surg Oncol 2007 0.92
17 Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery. J Proteome Res 2012 0.92
18 The dermal-based borderline melanocytic tumor: a categorical approach. J Am Acad Dermatol 2010 0.91
19 15-F(2t)-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts. Am J Physiol Heart Circ Physiol 2005 0.90
20 Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12. J Clin Oncol 2005 0.90
21 A combined treatment approach emphasizing impairment-based manual physical therapy for plantar heel pain: a case series. J Orthop Sports Phys Ther 2004 0.89
22 False identification of Coccidioides immitis: do molecular methods always get it right? J Clin Microbiol 2003 0.88
23 Male accessory glands of Drosophila melanogaster make a secreted angiotensin I-converting enzyme (ANCE), suggesting a role for the peptide-processing enzyme in seminal fluid. J Exp Biol 2007 0.87
24 Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003 0.87
25 IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2. Clin Cancer Res 2008 0.84
26 The addition of cervical thrust manipulations to a manual physical therapy approach in patients treated for mechanical neck pain: a secondary analysis. J Orthop Sports Phys Ther 2010 0.84
27 Clinical measures associated with dynamic balance and functional movement. J Strength Cond Res 2014 0.84
28 Melanoma. J Natl Compr Canc Netw 2006 0.83
29 Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study. Lipids Health Dis 2009 0.82
30 Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 2003 0.82
31 Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients. Proteomics 2013 0.81
32 A label-free selected reaction monitoring workflow identifies a subset of pregnancy specific glycoproteins as potential predictive markers of early-onset pre-eclampsia. Mol Cell Proteomics 2013 0.80
33 A specific PTPRC/CD45 phosphorylation event governed by stem cell chemokine CXCL12 regulates primitive hematopoietic cell motility. Mol Cell Proteomics 2013 0.79
34 A hierarchical statistical modeling approach to analyze proteomic isobaric tag for relative and absolute quantitation data. Bioinformatics 2013 0.79
35 An assessment of peptide enrichment methods employing mTRAQ quantification approaches. Anal Chem 2012 0.78
36 Head and neck melanoma in the sentinel lymph node era. Arch Otolaryngol Head Neck Surg 2007 0.78
37 Short- and long-term clinical outcomes following a standardized protocol of orthopedic manual physical therapy and exercise in individuals with osteoarthritis of the hip: a case series. J Man Manip Ther 2012 0.76
38 Automation to improve efficiency of field expedient injury prediction screening. J Strength Cond Res 2012 0.76
39 Reliability of lower quarter physical performance measures in healthy service members. US Army Med Dep J 2011 0.76
40 Stiff-person syndrome: a rare presentation for breast cancer. Breast J 2004 0.75
41 Changes in dynamic plantar pressure during loaded gait. Phys Ther 2013 0.75
42 Baseline Examination Factors Associated With Clinical Improvement After Dry Needling in Individuals With Low Back Pain. J Orthop Sports Phys Ther 2015 0.75
43 A 35-year-old woman with asthma and polycystic lung disease. Chest 2002 0.75